LL-37 (1-4, 17-27)

General Information


DRACP ID  DRACP03458

Peptide Name   LL-37 (1-4, 17-27)

Sequence  LLGDFKRIVQRIKDF

Sequence Length  15

UniProt ID  P49913 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP03458

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C86H142N24O21

Absent amino acids  ACEHMNPSTWY

Common amino acids  DFIKLR

Mass  209813

Pl  10.77

Basic residues  4

Acidic residues  2

Hydrophobic residues  7

Net charge  2

Boman Index  -3330

Hydrophobicity  -8.67

Aliphatic Index  123.33

Half Life 
  Mammalian: 5.5 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  1

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 16637646

Title  Solution structures of human LL-37 fragments and NMR-based identification of a minimal membrane-targeting antimicrobial and anticancer region

Doi Not available

Year  2006

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  3394

DRACP is developed by Dr.Zheng's team.